Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Ruiz

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 16, 2023
ALPINE2: Efficacy and safety of 14-day vs 28-day inhaled aztreonam for Pa eradication in children with cystic fibrosisFrancis J Gilchrist, Stephanie Bui, Silvia Gartner, et al.
Thorax|September 4, 2025
Spirometry thresholds for clinical trial eligibility: time for urgent re-evaluationIdan Bokobza, Melanie Le Sayec, Cara Bossley, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 12, 2020
Minimal change in structural, functional and inflammatory markers of lung disease in newborn screened infants with cystic fibrosis at one yearGwyneth Davies, Lena P Thia, Janet Stocks, et al.
Contemporary Clinical Trials Communications|May 7, 2024
Levelling the playing field through the London Network of the UK clinical trials accelerator platformJessie Matthews, Rebecca Dobra, Gemma Wilson, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 16, 2023
ALPINE2: Efficacy and safety of 14-day vs 28-day inhaled aztreonam for Pa eradication in children with cystic fibrosisFrancis J Gilchrist, Stephanie Bui, Silvia Gartner, et al.
Thorax|September 4, 2025
Spirometry thresholds for clinical trial eligibility: time for urgent re-evaluationIdan Bokobza, Melanie Le Sayec, Cara Bossley, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 12, 2020
Minimal change in structural, functional and inflammatory markers of lung disease in newborn screened infants with cystic fibrosis at one yearGwyneth Davies, Lena P Thia, Janet Stocks, et al.
Contemporary Clinical Trials Communications|May 7, 2024
Levelling the playing field through the London Network of the UK clinical trials accelerator platformJessie Matthews, Rebecca Dobra, Gemma Wilson, et al.
Pageof 2